Rodger Novak, President at CRISPR Therapeutics AG (CRSP), sold 100,000 shares at $70.27 ($7.0M) on 2020-05-26, disclosed to the SEC on 2020-05-27.
Open-market sale of $7.0M CRSP by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.01 | 13,384 | $937K | 13.3% |
| 2 | $70.01 | 13,384 | $937K | 13.3% |
| 3 | $70.27 | 36,616 | $2.6M | 36.7% |
| 4 | $70.27 | 36,616 | $2.6M | 36.7% |
| Total | $70.20 avg | 100,000 | $7.0M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-23 | $6.4M | — | Filing → |
| CRSP | SELL | 2020-12-02 | $6.3M | — | Filing → |
| CRSP | SELL | 2020-10-13 | $2.5M | — | Filing → |